Fagron completed the acquisition of a book of business of Amara.

Fagron, a pharmaceutical company, completed the acquisition of a book of business of Amara, a Polish pharmaceutical manufacturer. Financial terms were not disclosed. This deal support Fagron’s strategy to diversify its presence in dynamic markets and highlight its disciplined M&A approach as a driver of sustainable growth.